Resources

Type of publications
Regions
Diseases

5192 results found

2024 ∙ ATAGI

ATAGI statement on the transition from quadrivalent to trivalent seasonal influenza vaccines in Australia

  • Recommendation
  • Western Pacific
  • Australia
  • Influenza
Download:
2024 ∙ Su Hyun Lim, Mona Hersi, Ramya Krishnan, Joshua Montroy, Bonnie Rook, Kelly Farrah, Yung-En Chung, Adrienne Stevens, Joseline Zafack, Eva Wong, Nicole Forbes, April Killikelly, Kelsey Young, Matthew Tunis

COVID-19 vaccine evidence monitoring assisted by artificial Intelligence: An emergency system implemented by the Public Health Agency of Canada to capture and describe the trajectory of evolving pandemic vaccine literature

  • Americas
  • Canada
  • COVID-19
Download:
2024

CoPI - List of core members

  • Functioning
  • Africa
  • Mozambique
  • health policy
Download:
2024 ∙ Yemane Berhane, Telahun Teka, Meseret Zelalem, Yohannes Lakew, Amha Mekasha, Bogale Worku, Genet G/Medhin, Liya Wassie, Liya Wondwossen, Mulat Nigus, Samuel Teshome, Shiferaw Mitiku, Solomon Tessema Memirie, Teferi Fenta, Workeabeba Abebe, Yirgu Gebrehiwot

The Ethiopian National Immunization Technical Advisory Group (E-NITAG): Establishment, Achievements and the Future

  • Functioning
  • Africa
  • Ethiopia
Download:
2024 ∙ NIAC

NIAC updated recommendations for COVID-19 primary schedule vaccination

  • Recommendation
  • Europe
  • Ireland
  • COVID-19
Download:
2024 ∙ ACIP

Use of the Pfizer Pentavalent Meningococcal Vaccine Among Persons Aged ≥10 Years: Recommendations of the Advisory Committee on Immunization Practices ― United States, 2023

  • Recommendation
  • Americas
  • United States of America
  • Meningococcal disease
Download:
2024 ∙ ACIP

Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024–25 Influenza Season

  • Recommendation
  • Americas
  • United States of America
  • Influenza
Download:
2024 ∙ ACIP

Use of Respiratory Syncytial Virus Vaccines in Adults Aged ≥60 Years: Updated Recommendations of the ACIP — United States, 2024

  • Recommendation
  • Americas
  • United States of America
  • older adults
  • RSV (Respiratory syncytial virus)
Download:
2024 ∙ ACIP

ACIP Evidence to Recommendations for Use of Protein Subunit RSV vaccines (GSK Arexvy or Pfizer Abrysvo) in All Adults Aged ≥75 years and in Adults Aged 60–74 at Increased Risk of Severe RSV Disease

  • Background paper
  • Americas
  • United States of America
  • older adults
  • EtR framework
  • RSV (Respiratory syncytial virus)
2024 ∙ ACIP

ACIP Evidence to Recommendations for Use of Moderna RSV Vaccine (mResvia) in All Adults Aged ≥75 years and in Adults Aged 60–74 at Increased Risk of Severe RSV Disease

  • Background paper
  • Americas
  • United States of America
  • older adults
  • EtR framework
  • RSV (Respiratory syncytial virus)
Loading...